K P Ng1, D Chanouzas, B Fallouh, J Baharani. 1. Renal Department, Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust, Birmingham, UK. khaiping@doctors.org.uk
Abstract
BACKGROUND: Severe acute kidney injury (AKI) occurs in 2-7% of all hospital admissions and is an independent poor prognostic marker. Nevertheless, information on the long-term outcome of AKI and the factors influencing this is limited. AIM: To describe the short- and long-term outcome of patients requiring renal replacement therapy (RRT) for severe AKI and to examine factors affecting patient survival and renal recovery. DESIGN AND METHODS: Single centre retrospective analysis of 481 consecutive patients over a period of 39 months. FOLLOW-UP: 12 months. PRIMARY AND SECONDARY OUTCOMES: overall mortality and RRT dependency at 30 days, 90 days and 1 year. RESULTS: Survival at 30 days, 90 days and 1 year was 54.4, 47.2 and 37.6%, respectively. RRT independency at 30 days, 90 days and 1 year was 35.2, 27.2 and 25.8%, respectively. Of those RRT independent at 90 days, 55% had ongoing chronic kidney disease. There were two distinct groups of patients: Group A (haemofiltration in ITU) and Group B (intermittent haemodialysis in the renal unit). Patient survival was worse in Group A while RRT independence was higher. Independent predictors of survival included renal cause of AKI and lower CI score in Group A and renal or post-renal cause of AKI, younger age and the absence of malignancy in Group B. Independent predictors of renal recovery included the presence of sepsis in Group A and pre- or post-renal cause of AKI in Group B. CONCLUSIONS: The short- and long-term survival outcome of severe AKI requiring RRT remains poor. Among those who survive, a significant number either continue to require RRT or have residual renal impairment necessitating ongoing follow-up.
BACKGROUND: Severe acute kidney injury (AKI) occurs in 2-7% of all hospital admissions and is an independent poor prognostic marker. Nevertheless, information on the long-term outcome of AKI and the factors influencing this is limited. AIM: To describe the short- and long-term outcome of patients requiring renal replacement therapy (RRT) for severe AKI and to examine factors affecting patient survival and renal recovery. DESIGN AND METHODS: Single centre retrospective analysis of 481 consecutive patients over a period of 39 months. FOLLOW-UP: 12 months. PRIMARY AND SECONDARY OUTCOMES: overall mortality and RRT dependency at 30 days, 90 days and 1 year. RESULTS: Survival at 30 days, 90 days and 1 year was 54.4, 47.2 and 37.6%, respectively. RRT independency at 30 days, 90 days and 1 year was 35.2, 27.2 and 25.8%, respectively. Of those RRT independent at 90 days, 55% had ongoing chronic kidney disease. There were two distinct groups of patients: Group A (haemofiltration in ITU) and Group B (intermittent haemodialysis in the renal unit). Patient survival was worse in Group A while RRT independence was higher. Independent predictors of survival included renal cause of AKI and lower CI score in Group A and renal or post-renal cause of AKI, younger age and the absence of malignancy in Group B. Independent predictors of renal recovery included the presence of sepsis in Group A and pre- or post-renal cause of AKI in Group B. CONCLUSIONS: The short- and long-term survival outcome of severe AKI requiring RRT remains poor. Among those who survive, a significant number either continue to require RRT or have residual renal impairment necessitating ongoing follow-up.
Authors: Antoine G Schneider; Rinaldo Bellomo; Sean M Bagshaw; Neil J Glassford; Serigne Lo; Min Jun; Alan Cass; Martin Gallagher Journal: Intensive Care Med Date: 2013-02-27 Impact factor: 17.440
Authors: Riccardo Maria Fagugli; Francesco Patera; Sara Battistoni; Francesca Mattozzi; Giovanni Tripepi Journal: J Nephrol Date: 2014-06-17 Impact factor: 3.902
Authors: M Schmitz; P J Heering; R Hutagalung; R Schindler; M I Quintel; F M Brunkhorst; S John; A Jörres Journal: Med Klin Intensivmed Notfmed Date: 2015-03-28 Impact factor: 0.840
Authors: Raghavan Murugan; Xiaoyan Wen; Nilesh Shah; Minjae Lee; Lan Kong; Francis Pike; Christopher Keener; Mark Unruh; Kevin Finkel; Anitha Vijayan; Paul M Palevsky; Emil Paganini; Melinda Carter; Michele Elder; John A Kellum Journal: Nephrol Dial Transplant Date: 2014-03-11 Impact factor: 5.992
Authors: Raphael Donadio Pitta; Juliano Gasparetto; Thyago Proença De Moraes; João Paulo Telles; Felipe Francisco Tuon Journal: Eur J Clin Microbiol Infect Dis Date: 2019-12-12 Impact factor: 3.267
Authors: Ilana Kopolovic; Kim Simmonds; Shelley Duggan; Mark Ewanchuk; Daniel E Stollery; Sean M Bagshaw Journal: BMC Nephrol Date: 2013-05-01 Impact factor: 2.388
Authors: Robert Faulhaber-Walter; Sebastian Scholz; Herrmann Haller; Jan T Kielstein; Carsten Hafer Journal: Int J Nephrol Renovasc Dis Date: 2016-05-23